phase readout
saveNCT06064825: Long Term Follow-up of the TREOCAPA Study (TREOCAPA-LT)
community read0 votes
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: Patency of the Ductus Arteriosus Acetaminophen Extreme Prematurity
view source ↗Data sources
last refreshed 3h ago
Found something off?
same company · ±60 days · 6
- approvalBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalApr 15, 2026
- approvalBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalApr 15, 2026
- approvalBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalApr 15, 2026
- approvalBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalApr 15, 2026
- approvalBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalApr 15, 2026
- approvalBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalApr 15, 2026
comments(0)
5-min edit window · permanent after that